These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21311975

  • 21. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M.
    Cancer Res; 2006 May 01; 66(9):4826-34. PubMed ID: 16651438
    [Abstract] [Full Text] [Related]

  • 22. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H, Yan D, Wang Y, Shi W, Liu T, Zhao C, Huo S, Duan J, Tao J, Zhai M, Luo P, Guo J, Tian L, Mageta L, Jou D, Zhang C, Li C, Lin J, Lv J, Li S, Lin L.
    Cancer Sci; 2019 Mar 01; 110(3):950-961. PubMed ID: 30648776
    [Abstract] [Full Text] [Related]

  • 23. Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3.
    Huang CY, Lin CS, Tai WT, Hsieh CY, Shiau CW, Cheng AL, Chen KF.
    Int J Radiat Oncol Biol Phys; 2013 Jul 01; 86(3):456-62. PubMed ID: 23474115
    [Abstract] [Full Text] [Related]

  • 24. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
    Schust J, Sperl B, Hollis A, Mayer TU, Berg T.
    Chem Biol; 2006 Nov 01; 13(11):1235-42. PubMed ID: 17114005
    [Abstract] [Full Text] [Related]

  • 25. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells.
    Kim SR, Bae MK, Kim JY, Wee HJ, Yoo MA, Bae SK.
    Biochem Biophys Res Commun; 2009 Sep 18; 387(2):342-7. PubMed ID: 19595669
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM, Mayes N, Koniaris LG, Cahill PA, McKillop IH.
    Liver Int; 2005 Apr 18; 25(2):445-57. PubMed ID: 15780071
    [Abstract] [Full Text] [Related]

  • 27. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
    Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL.
    Clin Cancer Res; 2010 Nov 01; 16(21):5189-99. PubMed ID: 20884624
    [Abstract] [Full Text] [Related]

  • 28. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
    Tang GS, Cai JM, Ni J, Xiang YS, Cui JG, Zhu D, Dong JR.
    Ai Zheng; 2006 Mar 01; 25(3):269-74. PubMed ID: 16536977
    [Abstract] [Full Text] [Related]

  • 29. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.
    Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387
    [Abstract] [Full Text] [Related]

  • 30. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, Feng G, Zou D, Wang H.
    Clin Cancer Res; 2013 Oct 01; 19(19):5372-80. PubMed ID: 23942093
    [Abstract] [Full Text] [Related]

  • 31. STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma.
    Tai WT, Chu PY, Shiau CW, Chen YL, Li YS, Hung MH, Chen LJ, Chen PL, Su JC, Lin PY, Yu HC, Chen KF.
    Clin Cancer Res; 2014 Nov 15; 20(22):5768-76. PubMed ID: 25248379
    [Abstract] [Full Text] [Related]

  • 32. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
    Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, Franchi L.
    Mol Immunol; 2009 May 15; 46(8-9):1867-77. PubMed ID: 19299019
    [Abstract] [Full Text] [Related]

  • 33. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
    Ashizawa T, Miyata H, Ishii H, Oshita C, Matsuno K, Masuda Y, Furuya T, Okawara T, Otsuka M, Ogo N, Asai A, Akiyama Y.
    Int J Oncol; 2011 May 15; 38(5):1245-52. PubMed ID: 21369699
    [Abstract] [Full Text] [Related]

  • 34. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M, Li C, Lin J, Javle M.
    Oncotarget; 2015 May 10; 6(13):10940-9. PubMed ID: 25883212
    [Abstract] [Full Text] [Related]

  • 35. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
    Galdiero M, Vitiello M, D'Isanto M, Raieta K, Galdiero E.
    Cytokine; 2006 Dec 10; 36(5-6):218-28. PubMed ID: 17258468
    [Abstract] [Full Text] [Related]

  • 36. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 37. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
    Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676
    [Abstract] [Full Text] [Related]

  • 38. Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells.
    Um HJ, Min KJ, Kim DE, Kwon TK.
    Biochem Biophys Res Commun; 2012 Oct 12; 427(1):24-9. PubMed ID: 22982675
    [Abstract] [Full Text] [Related]

  • 39. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
    Zhao W, Zhang T, Qu B, Wu X, Zhu X, Meng F, Gu Y, Shu Y, Shen Y, Sun Y, Xu Q.
    Anticancer Drugs; 2011 Jan 12; 22(1):79-88. PubMed ID: 20881478
    [Abstract] [Full Text] [Related]

  • 40. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.